Jane Wasman
2013
In 2013, Jane Wasman earned a total compensation of $2.2M as President, International, General Counsel and Corporate Secretary at Acorda Therapeutics, a 37% decrease compared to previous year.
Compensation breakdown
| Bonus | $2,500 |
|---|---|
| Non-Equity Incentive Plan | $302,525 |
| Option Awards | $988,861 |
| Salary | $515,167 |
| Stock Awards | $342,919 |
| Other | $7,650 |
| Total | $2,159,622 |
Wasman received $988.9K in option awards, accounting for 46% of the total pay in 2013.
Wasman also received $2.5K in bonus, $302.5K in non-equity incentive plan, $515.2K in salary, $342.9K in stock awards and $7.7K in other compensation.
Rankings
In 2013, Jane Wasman's compensation ranked 3,651st out of 12,286 executives tracked by ExecPay. In other words, Wasman earned more than 70.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,651 out of 12,286 | 70th |
Division Manufacturing | 1,243 out of 4,612 | 73rd |
Major group Chemicals And Allied Products | 337 out of 1,462 | 77th |
Industry group Drugs | 236 out of 1,156 | 80th |
Industry Biological Products, Except Diagnostic Substances | 33 out of 196 | 83rd |
Source: SEC filing on April 29, 2016.
Wasman's colleagues
We found six more compensation records of executives who worked with Jane Wasman at Acorda Therapeutics in 2013.
2013
Michael Rogers
Acorda Therapeutics
Chief Financial Officer
2013
Ron Cohen
Acorda Therapeutics
Chief Executive Officer
2013
Enrique Carrazana
Acorda Therapeutics
Chief Medical Officer
2013
Andrew Blight
Acorda Therapeutics
Chief Scientific Officer
2013
Lauren Sabella
Acorda Therapeutics
Chief Commercial Officer
2013
David Lawrence
Acorda Therapeutics